NCT05295693View on ClinicalTrials.gov

Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

May 25, 2023

Study Completion Date

May 25, 2023

Conditions
Coagulopathy
Interventions
DEVICE

Correlation of the Quantra with the TEG

"The purpose of this study is to evaluate the efficacy/reliability/validity of the Quantra device in patients with congenital heart disease for cardiac surgery on CPB.~The study if of investigational interest only. No clinical decisions will be made based on the results obtained by the Quantra device."

Trial Locations (1)

94305

Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER